I recently returned from the American College of Physicians (ACP) annual meeting in Washington, DC. The ACP is the largest medical specialty organization in the world, with 147,000 members spanning the spectrum from medical students starting off on their careers to seasoned clinicians in practice and medical school professors.
Read more about the ACP’s commitment to patient-centered care
As Shared Decision Making Month drew to a close at the end of March, I found myself reflecting on forces that get in the way of all patients sharing in their fateful health decisions. One potential collision is between clinical practice guidelines, with their related performance measures, and the preferences of informed patients.
Read more about the need for patient-centered clinical practice guidelines
New guidelines from the American College of Cardiology and the American Heart Association on the assessment of cardiovascular risk and the manipulation of cholesterol levels to mitigate that risk have certainly been in the news. The guidelines appropriately use high quality evidence to abandon old untested or unproven paradigms such as treatment to LDL targets and manipulation of non-HDL cholesterol as a secondary goal. In many ways, the new guidelines should simplify lipid management.
Read more about the guidelines for cardiovascular risk and cholesterol management
In 1621, just 40 miles south of the Informed Medical Decisions Foundation headquarters, the Pilgrims and the Wampanoag joined together to give thanks for the first successful harvest. Although today’s annual celebration is quite different from that first Thanksgiving, one thing remains the same—Thanksgiving is a time to give thanks. As this autumn holiday nears, we’d like to take a moment to reflect on the many blessings of 2013, as well as those of years past.
Read more about what we're thankful for this Thanksgiving
In a guidance statement published Tuesday in the Annals of Internal Medicine, the American College of Physicians (ACP) joined the heated discussion on PSA testing by endorsing a shared decision making approach for prostate cancer screening. The ACP Clinical Guidelines Committee developed this guidance statement after reviewing current guidelines on prostate cancer screening in the U.S.
Read more about what the new prostate cancer screening guidelines mean for men
The debate over the U.S. Preventive Services Task Force's (USPSTF) final recommendation on PSA testing continued this week. Michael Barry, president of the Informed Medical Decisions Foundation, and Mary McNaughton-Collins, medical director, each had an opportunity to speak on NPR radio programs about the USPSTF recommendation this week. They voiced their views on the recommendation—both from the perspective of the Foundation and as practicing primary care physicians.
Read more about what our docs have to say about this USPSTF recommendation
The U.S. Preventive Services Task Force (USPSTF) published their final recommendation on PSA testing in an Annals of Internal Medicine article this week. The panel advises against PSA-based prostate cancer screening for men of all ages. The rationale for this recommendation is based on the panel’s moderate certainty that the potential harms outweigh the benefits for all age groups. Based on clinical evidence from two large randomized trials evaluated by the panel, at most 1 out of 1,000 men screened will avoid dying from prostate cancer over 10 years, while many more men will be left with permanent disabilities from their treatment, such as incontinence (18 in 1,000) or impotence (29 in 1,000).
Read more about what we think is missing from the USPSTF recommendation on the PSA test